Qiming Venture Partners Portfolio Company Northmed Technology Debuts on STAR Market
In 2020, Qiming Venture Partners led the Series C round for NorthSea Therapeutics and continued to support the company's growth in its Series D round.
@author-1788515151757110
In 2020, Qiming Venture Partners led the Series C round for NorthSea Therapeutics and continued to support the company's growth in its Series D round.
Recognizing outstanding organizations and individuals who have forged ahead with remarkable achievements over the past year, setting new benchmarks for industry development.
Celebrating milestone moments with you at Qiming Venture Partners' portfolio companies
From one angle, this reflects China's influence in the global private equity market.
Thirteen years, over 100 portfolio companies, covering the full AI industry chain.
This is intended to encourage outstanding institutions and talent in private equity fund-of-funds and the broader fund industry, and to promote the healthy development of equity investment.
Join us in celebrating milestone moments for Qiming Venture Partners' portfolio companies
Build a shared framework for dialogue among industry, professional communities, and policymakers based on common understanding, driving the formation of foundational international norms of conduct.
Uncovering the Forces of Business Transformation Over the Next 3–5 Years
Celebrating milestone moments with Qiming Venture Partners' portfolio companies